For pharmacists, from Drug Topics: News and features for pharmacists about clinical trials, newly approved drugs, and new practices in clinical pharmacy
March 15, 2010
By:Drug Topics staff
An FDA-approved oral transmucosal fentanyl citrate, an opioid analgesic for cancer pain management, is being launched by Mallinckrodt Inc., a Covidien company.
 |
March 15, 2010
By:Mari Edlin
REMS for opioids may present some tough challenges for pharmacists.
|
March 15, 2010
By:Drug Topics staff
Cabazitaxel, an investigational compound under development by Sanofi-aventis, plus prednisone/prednisolone, is associated with overall survival and progression-free survival in patients with metastatic (advanced) hormone-refractory prostate cancer whose disease advanced after treatment with docetaxel-based chemotherapy.
|
March 15, 2010
By:Drug Topics staff
Norditropin FlexPro (somatropin [rDNA origin] injection, Novo Nordisk), a pre-filled injection pen for use in children and adults with growth hormone disorders, will be available this spring.
|
March 15, 2010
By:Drug Topics staff
The National Association of Chain Drug Stores (NACDS) awarded Rep. Marion Berry the NACDS Congressional Leadership Award for his ongoing support of pharmacy.
|
March 15, 2010
By:Kathryn Foxhall
The Institute of Medicine says more research is necessary comparing the advantages of different sites for vaccination.
|
March 15, 2010
By:Drug Topics staff
The FDA-approved Iprivask (desirudin for injection, Canyon Pharmaceuticals), now available, marks the first direct thrombin inhibitor (DTI) OK'd for the prevention of deep vein thrombosis (DVT).
|
| 
| Drug Topics is a monthly news magazine, guided by a board of pharmacy leaders, reporting on all phases of community, retail, and health-system issues and trends. We cover managed care and professional, national, and state activities as well as new therapies involving prescription and OTC drugs.
|
ARCHIVES | RSS | E-NEWS | DIGITAL EDITION|
 | | | |
| Which pharmacists' membership organization best represents your concerns? | | | Local | | 6% | | | Regional | | 0% | | | State | | 35% | | | National | | 24% | | | Specialized interest group | | 6% | | | Other | | 0% | | | None | | 29% | |
| |  | | | |
|
|
  Drug Topics archives are now available on ModernMedicine.com, a new online resource designed to meet the evolving needs of physicians.
Register now (it's free and quick) or Find out more.
Keep visiting Drug Topics for fresh content, news, opinions, editor's blogs and more.  | 
